Medicine & Life Sciences
Leishmania donovani
100%
Visceral Leishmaniasis
90%
DNA Vaccines
89%
Vaccines
55%
Interleukin-4
51%
Parasites
46%
Leishmania LACK antigen
38%
Antigens
35%
Receptors for Activated C Kinase
28%
Infections
26%
T-Lymphocytes
22%
Asymptomatic Infections
22%
Leishmaniasis
21%
Leishmania
21%
Skin
20%
Interleukin-12
19%
Amino Acid Sequence
17%
Immunization
15%
Immunity
15%
Vaccination
14%
DNA
10%
Proteins
6%
Agriculture & Biology
recombinant vaccines
98%
visceral leishmaniasis
96%
Leishmania donovani
96%
vaccines
63%
interleukin-4
54%
antigens
44%
Leishmania
33%
parasites
30%
T-lymphocytes
26%
infection
23%
interleukin-12
19%
Leishmania major
19%
leishmaniasis
18%
mice
17%
DNA
15%
immunization
14%
protective effect
14%
vaccination
13%
immunity
12%
phosphotransferases (kinases)
12%
immune response
12%
amino acid sequences
10%
receptors
10%
proteins
4%